Epoprostenol Sodium Patent Expiration
Epoprostenol Sodium was first introduced by Glaxosmithkline Llc
Epoprostenol Sodium Patents
Given below is the list of patents protecting Epoprostenol Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Veletri | US8318802 | Epoprostenol formulation and method of making thereof | Mar 15, 2027 | Actelion |
| Veletri | US8598227 | Epoprostenol formulation and method of making thereof | Feb 02, 2027 | Actelion |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Epoprostenol Sodium's patents.
Latest Legal Activities on Epoprostenol Sodium's Patents
Given below is the list recent legal activities going on the following patents of Epoprostenol Sodium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 15 May, 2024 | US8318802 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 19 May, 2021 | US8598227 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 14 May, 2020 | US8318802 |
| Email Notification Critical
| 05 Sep, 2014 | US8598227 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 05 Sep, 2014 | US8598227 |
| Filing Receipt - Replacement | 05 Sep, 2014 | US8598227 |
| Electronic Review Critical
| 23 Jul, 2014 | US8598227 |
| Email Notification Critical
| 23 Jul, 2014 | US8598227 |
| Mail Pre-Exam Notice | 23 Jul, 2014 | US8598227 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 22 Jul, 2014 | US8318802 |
Epoprostenol Sodium's Family Patents
